Contineum Therapeutics, Inc

San Diego Biomedical Research Institute (SDBRI) is located in Science Park within the Torrey Pines region of San Diego, California. It is in close proximity to leading organizations such as The Scripps Research Institute and the Salk Institute for Biological Studies, fostering collaboration and resource sharing within the scientific community. Dedicated to improving human lives, SDBRI conducts research funded primarily by the National Institutes of Health, supplemented by private donations. These contributions facilitate the acquisition of laboratory supplies and equipment as well as the recruitment of personnel to advance their research initiatives. Generated from the website

The Lowy Medical Research Institute (LMRI) in La Jolla, California, is committed to preventing vision loss in individuals affected by macular telangiectasia type 2 (MacTel). Through collaboration, LMRI investigators study potential causes of MacTel and work towards developing and delivering new therapies to patients. In addition to its research efforts, LMRI engages with the community through initiatives such as the Lowy Symposium and informational webinars aimed at raising awareness about MacTel. The institute's mission reflects its dedication to advancing vision science and improving the lives of those affected by this condition. Generated from the website

The Calibr Skaggs Institute for Innovative Medicine is a pioneering nonprofit drug discovery hub located in La Jolla, California, dedicated to accelerating the development of new medicines for critical unmet medical needs. As a division of Scripps Research, the largest private nonprofit biomedical research organization in the United States, Calibr Skaggs leverages advanced scientific approaches and technologies to transition groundbreaking discoveries from the lab to clinical applications. With a focus on fostering collaboration, Calibr Skaggs partners with leading companies, researchers, and nonprofits to develop novel therapies targeting a wide range of diseases, including neglected and infectious diseases, cancer, and chronic conditions. Their self-sustaining funding model allows for continuous reinvestment into research and development, driving impactful solutions for human health. Generated from the website